VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CTNM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CTNMContineum Therapeutics, Inc.
$9.24$345M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCTNMQuarterly Financials

Contineum Therapeutics, Inc. (CTNM) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Contineum Therapeutics, Inc. (CTNM) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

CTNM Income Statement

Quarterly statement

CTNM Income Statement

Contineum Therapeutics, Inc. (CTNM) annual income statement — 5-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q1'23Q4'22
Sales/Revenue000000000000000
Revenue Growth %---------------
Cost of Goods Sold81K00000000000000
COGS % of Revenue---------------
Gross Profit-81K00000000000000
Gross Margin %---------------
Gross Profit Growth %---------------
Operating Expenses20.97M17.43M16.9M17.11M14.93M17.9M18.11M-84.74M12.97M10.94M9.93M9.68M8.07M5.12M5.45M
OpEx % of Revenue---------------
Selling, General & Admin4.98M4.73M5.26M4.36M3.94M3.84M4.4M4.03M3.25M3.04M2.15M1.66M1.57M1.48M1.5M
SG&A % of Revenue---------------
Research & Development15.98M12.7M11.65M12.76M10.99M14.06M13.71M13.02M9.73M7.9M7.78M8.01M6.5M3.63M3.95M
R&D % of Revenue---------------
Other Operating Expenses0000000-1000K0000000
Operating Income-20.97M-17.43M-16.9M-17.11M-14.93M-17.9M-18.11M84.74M-12.97M-10.94M-9.93M-9.68M-8.07M-5.12M-5.45M
Operating Margin %---------------
Operating Income Growth %-40.41%2.65%6.66%-120.2%-15.09%-63.58%-82.38%975.79%-60.79%--94.13%-77.57%---
EBITDA-20.89M-17.29M-16.82M-17.03M-14.85M-17.82M-18.03M84.82M-12.91M-10.88M-9.87M-9.64M-8.03M-5.04M-5.37M
EBITDA Margin %---------------
EBITDA Growth %-40.63%2.97%6.72%-120.08%-15.02%-63.75%-82.71%979.93%-60.88%--95.74%-79.56%---
D&A (Non-Cash Add-back)81K134K83K85K81K79K78K75K62K60K61K37K43K73K81K
EBIT-20.97M-17.43M-16.9M-17.11M-14.93M-17.9M-18.11M-14.56M-10.27M-9.01M-8.42M-7.93M-6.37M-4.73M-7.41M
Net Interest Income2.36M2.34M2.5M2.01M1.96M2.03M2.25M2.53M2.74M2M1.64M1.79M1.74M309K241K
Interest Income2.36M2.34M2.5M2.01M1.96M2.03M2.25M2.53M2.74M2M1.64M1.79M1.74M401K342K
Interest Expense000000000000092K101K
Other Income/Expense2.27M2.27M2.45M1.96M2.14M1.86M2.12M-99.31M2.71M1.94M1.51M1.75M1.7M291K-2.06M
Pretax Income-18.7M-15.15M-14.46M-15.16M-12.79M-16.04M-15.99M-14.56M-10.27M-9.01M-8.42M-7.93M-6.37M-4.82M-7.51M
Pretax Margin %---------------
Income Tax00000000000-161K-118K00
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%2.03%1.85%0%0%
Net Income-18.7M-15.15M-14.46M-15.16M-12.79M-16.04M-15.99M-14.56M-10.27M-9.01M-8.42M-7.77M-6.25M-4.82M-7.51M
Net Margin %---------------
Net Income Growth %-46.16%5.52%9.59%-4.06%-24.59%-78.04%-89.97%-87.48%-64.25%--74.48%-3.42%---
Net Income (Continuing)-18.7M-15.15M-14.46M-15.16M-12.79M-16.04M-15.99M-14.56M-10.27M-9.01M-8.42M-7.77M-6.25M-4.82M-7.51M
Discontinued Operations000000000000000
Minority Interest000000000000000
EPS (Diluted)-0.49-0.40-0.39-0.49-0.45-0.62-0.62-0.56-0.40-0.35-0.33-0.05-0.25-0.19-0.30
EPS Growth %-8.89%35.48%37.1%12.5%-12.5%-77.14%-87.88%-1078.95%-60%--73.68%84.17%---
EPS (Basic)-0.49-0.40-0.39-0.49-0.45-0.62-0.62-0.56-0.40-0.35-0.33-0.05-0.25-0.19-0.30
Diluted Shares Outstanding38.39M37.47M37.34M30.86M28.12M25.9M25.87M25.85M25.74M25.72M25.72M25.13M25.13M25.72M25.13M
Basic Shares Outstanding38.39M37.47M37.34M30.86M28.12M25.9M25.87M25.85M25.74M25.72M25.72M25.13M25.13M25.72M25.13M
Dividend Payout Ratio---------------